REGENERON PHARMACEUTICALS, INC. Quarterly Lessee, Operating Lease, Liability, to be Paid in USD from Q1 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Regeneron Pharmaceuticals, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q1 2019 to Q4 2023.
  • Regeneron Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending December 31, 2023 was $103M.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $103M Dec 31, 2023 10-K 2024-02-05
Q4 2019 $26.1M Dec 31, 2019 10-K 2020-02-07
Q3 2019 $28.4M Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $30.7M Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $32.5M Mar 31, 2019 10-Q 2019-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.